Clinical Trial Update: Study to Evaluate the Efficacy and Safety of Daglutril Compared to Placebo on Top of Losartan in Type 2 Diabetics With Overt Nephropathy and Well Controlled Hypertension [Phase 2]

View source ↗

Summary

Phase 2 study evaluating the efficacy and safety of daglutril vs placebo added to losartan in adults with type 2 diabetes, overt nephropathy, and well-controlle…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Nephropathy
• Hypertension
• Type 2 Diabetes Mellitus

Drugs mentioned

• Daglutril (daglutril)
• Losartan (losartan)

Snippet

Sponsor: Solvay Pharmaceuticals | Conditions: Hypertension | Phase 2 | Status: COMPLETED